Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases

@inproceedings{Chi2012DosimetricSF,
  title={Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases},
  author={Alexander Chi and Zhongxing Liao and Nam Nguyen and Jiahong Xu and James Welsh and Si Young Jang and Carol J. Howe and Ritsuko Komaki},
  booktitle={PloS one},
  year={2012}
}
BACKGROUND No selection criteria for helical tomotherapy (HT) based stereotactic ablative radiotherapy (SABR) to treat early stage non-small cell lung cancer (NSCLC) or solitary lung metastases has been established. In this study, we investigate the dosimetric selection criteria for HT based SABR delivering 70 Gy in 10 fractions to avoid severe toxicity in the treatment of centrally located lesions when adequate target dose coverage is desired. MATERIALS AND METHODS 78 HT-SABR plans for… CONTINUE READING
6 Citations
31 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Similar Papers

Loading similar papers…